摘要
糖尿病肾病（diabetic nephropathy,DN）是糖尿病最严重的微血管并发症,尿白蛋白排泄率是DN早期诊断最为常用的临床指标。但是,一些大型的临床研究显示其在DN诊断上存在一定的局限性。英国前瞻性糖尿病（diabetes mellitus,DM）研究（UKPDS）[1]在平均随访15年的过程中没有出现肾功能损害。
出处
《中国中西医结合肾病杂志》
2011年第6期471-474,共4页
Chinese Journal of Integrated Traditional and Western Nephrology
参考文献29
-
1Retnakaran R, Cull CA, Thorne KI, et al. Risk Factors for Renal Dysfunction in Type 2 Diabetes U. K. Prospective Diabetes Study 74. Diabetes,2006,55 (6) : 1832 - 1839.
-
2Kamijo A, Sugaya T, Hikawa A, et al. Urinary fatty acid binding protein as a new clinical marker for the progression of chronic re- nal disease. Rinsho Byori ,2003,51 ( 3 ) :219 - 224.
-
3Kamijo - Ikemori A, Sugaya T, Yasuda T, et al. Clinical signifi- cance of urinary liver - type fatty acid binding protein in diabetic nephropathy of type 2 diabetic patients. Diabetes Care, 2011,34 (3) :691 -696.
-
4Nielsen SE, Sugaya T, Hovind P, et al. Urinary liver - type acid binding protein predicts progression to nephropathy in type 1 dia- betic patients. Diabetes Care ,2010,33 (6) : 1320 - 1324.
-
5Moil K, Nakao K. Neutrophil gelatinase - associated lipocalin as the real - time indicator of active kidney damage. Kidney Int, 2007,71 (10) :967 - 970.
-
6Nielsen SE, Schioedt KJ, Astrup AS, et al. Neutrophil gelatinase -associated lipocalin (NGAL) and Kidney injury molecule 1 ( KIM - 1 ) in patients with diabetic nephropathy: a cross - sec- tional study and the effects of lisinopril. Diabet Med, 2010,27 (10) :1144 - 1150.
-
7Jain S, De Petris, Hoshi M, et al. Expression profiles of podocytes exposed to high glucose reveal new insights into early diabetic glomerulopathy. Lab Invest,2011,91 (4) :488 - 496.
-
8Bo!ignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelati- nase- associated lipocalin(NGAL) and progression of chronic kidney disease. J Am Soc Nephrol,2009,4(2) :337 - 344.
-
9Vaidya VS, Niewczas MA, Ficociello LH. Regression of mi- croalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule - 1, and N - acetyl - β - D - glucosaminidase. Kidney Int, 2011,79 (4) :464 -470.
-
10Waanders F, Vaidva VS, van Goor H, et al. Effect of renin - an- giotensin aldosterone system inhibiton, dietary sodium restric- tion, and /or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease:a post hoc analysis of a randomized controlled trial. Am J Kidney Dis, 2009,53(1) :16 -25.
同被引文献22
-
1Choi DW. Bench to bedside:the glutamate connection. Science, 1992,258 (5080) : 241 - 243.
-
2Adams JU. Building the bridge from bench to bedside. Nat Rev Drug Discov,2008,7 (6) :463 - 464.
-
3Littman BH, Di Mario L, Plebani M, et al. What' s next intransla- tional medicine. Clin Sci ( Lond), 2007,112 ( 4 ) : 217 - 227.
-
4Butler D. Cross the valley of death. Nature, 2008,453:840 - 842.
-
5Scott A. Waldman, Andre Terzic. Clinical and Translational Sci- ence: From Bench - Bedside to Global Village. Clinical and Translational Science,2010,3 (5) :254 - 257.
-
6Geraghty J. Adenomatous polyposis coli and translationalmedi- cine. Lancet, 1996,348 (9025) :422.
-
7Elias Z. The NIH Roadmap. Seienee,2003,302(3) :63 - 64,72.
-
8Editoria 1. Human capital in translational research. Nature Re- views Drug Discovery,2008,7(6) :461.
-
9阴祯宏,徐婉珍,肖红丽.转化医学在中国.中华医学会第12次全国医学科学研究管理学学术年会,2010,8:92-95.
-
10刘志红 黎磊石.亟需努力造就一批临床医学科学家[J].肾脏病与透析肾移植杂志,2000,9(1):1-2.
-
1黄海华,李雯霞,许文琼,刘建英.短期应用胰岛素泵治疗糖尿病36例临床观察[J].中华综合临床医学杂志（北京）,2005,7(9):44-45.
-
2许樟荣,钱荣立.英国前瞻性糖尿病研究(UKPDS)简介[J].中国糖尿病杂志,1999,7(2):117-118. 被引量：70
-
3高月,吴佳丽.糖尿病大血管病变的危险因素[J].中国误诊学杂志,2006,6(8):1439-1440. 被引量：1
-
4姚军,高妍.餐后高血糖及其评价[J].中国实用内科杂志,2004,24(7):395-396. 被引量：47
-
5张晓凡,李素霞,李会会.胰岛素泵强化降糖治疗2型糖尿病的疗效观察[J].浙江临床医学,2006,8(12):1270-1270. 被引量：1
-
6陆惠华.重视糖尿病并存高血压患者的血压控制[J].老年医学与保健,2005,11(2):74-76.
-
7陈璐璐.专家专题报告2：降糖药物与β细胞[J].中华内分泌代谢杂志,2014,30(12):1150-1151. 被引量：1
-
8罗国春,翁建平.糖尿病患者强化血糖控制的同时需重视低血糖的防治[J].广东医学,2003,24(10):1031-1032. 被引量：28
-
9杨锐,方孝俊.重视糖尿病合并高血压的防治[J].健康大视野（医学版）,2006,14(12):86-86.
-
10韩佳琳,张洁.新诊断2型糖尿病强化治疗与蜜月期[J].实用糖尿病杂志,2010,6(1):59-60. 被引量：3
